fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Levofloxacin

14 general benefit · 10 not a benefit

Act Levofloxacin · DIN 02315424 · 250 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Act Levofloxacin · DIN 02315424 Manufacturer: Teva Canada Limited; listing date 2009-09-30 Health Canada: Marketed since 2025-10-16 · brand TEVA-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Act Levofloxacin: Formulary list price $1.20 per unit (the source does not state the unit; exact figure $1.2038). What the ministry pays, not the patient.

Ministry pays: $1.2038 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02315424)

Source record
DIN 02315424: Act Levofloxacin Raw flags: sec3=Y Item: 084000051; group id 134; item number 0225; lccId None; manufacturer id TEV Source form: Tab; strength: 250mg Recorded listing: General benefit Source prices (unrounded): $1.2038; ministry $1.2038 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02315424 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=80096
Interchangeable products
Apo-Levofloxacin · DIN 02284707 · $1.2038 Jamp Levofloxacin · DIN 02508443 · $1.2038 Levaquin · DIN 02236841 · not recorded Mint-Levofloxacin · DIN 02505797 · $1.2038 Novo-Levofloxacin · DIN 02248262 · $1.2038 Riva-Levofloxacin · DIN 02492725 · $1.2038 Sandoz Levofloxacin · DIN 02298635 · $1.2038
Shortage status: discontinued (August 28, 2025, reported by TEVA CANADA LIMITED); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02315424
Shortage record checked October 6, 2026

Apo-Levofloxacin · DIN 02284707 · 250 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Levofloxacin · DIN 02284707 Manufacturer: Apotex Inc.; listing date 2009-09-30 Health Canada: Marketed since 2009-06-24 · brand APO-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Apo-Levofloxacin: Formulary list price $1.20 per unit (the source does not state the unit; exact figure $1.2038). What the ministry pays, not the patient.

Ministry pays: $1.2038 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02284707)

Source record
DIN 02284707: Apo-Levofloxacin Raw flags: sec3=Y Item: 084000051; group id 134; item number 0225; lccId None; manufacturer id APX Source form: Tab; strength: 250mg Recorded listing: General benefit Source prices (unrounded): $1.2038; ministry $1.2038 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02284707 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77026
Interchangeable products
Act Levofloxacin · DIN 02315424 · $1.2038 Jamp Levofloxacin · DIN 02508443 · $1.2038 Levaquin · DIN 02236841 · not recorded Mint-Levofloxacin · DIN 02505797 · $1.2038 Novo-Levofloxacin · DIN 02248262 · $1.2038 Riva-Levofloxacin · DIN 02492725 · $1.2038 Sandoz Levofloxacin · DIN 02298635 · $1.2038
Shortage status: shortage reported ended May 1, 2026 (report last updated May 1, 2026); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02284707
Shortage record checked October 6, 2026

Jamp Levofloxacin · DIN 02508443 · 250 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Jamp Levofloxacin · DIN 02508443 Manufacturer: Jamp Pharma Corporation; listing date 2024-09-27 Health Canada: Marketed since 2024-07-19 · brand JAMP LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Jamp Levofloxacin: Formulary list price $1.20 per unit (the source does not state the unit; exact figure $1.2038). What the ministry pays, not the patient.

Ministry pays: $1.2038 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02508443)

Source record
DIN 02508443: Jamp Levofloxacin Raw flags: sec3=Y Item: 084000051; group id 134; item number 0225; lccId None; manufacturer id JPC Source form: Tab; strength: 250mg Recorded listing: General benefit Source prices (unrounded): $1.2038; ministry $1.2038 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02508443 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99781
Interchangeable products
Act Levofloxacin · DIN 02315424 · $1.2038 Apo-Levofloxacin · DIN 02284707 · $1.2038 Levaquin · DIN 02236841 · not recorded Mint-Levofloxacin · DIN 02505797 · $1.2038 Novo-Levofloxacin · DIN 02248262 · $1.2038 Riva-Levofloxacin · DIN 02492725 · $1.2038 Sandoz Levofloxacin · DIN 02298635 · $1.2038
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02508443
Shortage record checked October 6, 2026

Sandoz Levofloxacin · DIN 02298635 · 250 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Sandoz Levofloxacin · DIN 02298635 Manufacturer: Sandoz Canada Inc.; listing date 2009-09-30 Health Canada: Marketed since 2009-06-24 · brand SANDOZ LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG · company Sandoz canada incorporated · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Sandoz Levofloxacin: Formulary list price $1.20 per unit (the source does not state the unit; exact figure $1.2038). What the ministry pays, not the patient.

Ministry pays: $1.2038 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02298635)

Source record
DIN 02298635: Sandoz Levofloxacin Raw flags: sec3=Y Item: 084000051; group id 134; item number 0225; lccId None; manufacturer id SDZ Source form: Tab; strength: 250mg Recorded listing: General benefit Source prices (unrounded): $1.2038; ministry $1.2038 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02298635 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=78395
Interchangeable products
Act Levofloxacin · DIN 02315424 · $1.2038 Apo-Levofloxacin · DIN 02284707 · $1.2038 Jamp Levofloxacin · DIN 02508443 · $1.2038 Levaquin · DIN 02236841 · not recorded Mint-Levofloxacin · DIN 02505797 · $1.2038 Novo-Levofloxacin · DIN 02248262 · $1.2038 Riva-Levofloxacin · DIN 02492725 · $1.2038
Shortage status: resolved shortage (ended July 21, 2025); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02298635
Shortage record checked October 6, 2026

Act Levofloxacin · DIN 02315432 · 500 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Act Levofloxacin · DIN 02315432 Manufacturer: Teva Canada Limited; listing date 2009-09-30 Health Canada: Marketed since 2025-10-16 · brand TEVA-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Act Levofloxacin: Formulary list price $1.37 per unit (the source does not state the unit; exact figure $1.3718). What the ministry pays, not the patient.

Ministry pays: $1.3718 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02315432)

Source record
DIN 02315432: Act Levofloxacin Raw flags: sec3=Y Item: 084000049; group id 134; item number 0226; lccId None; manufacturer id TEV Source form: Tab; strength: 500mg Recorded listing: General benefit Source prices (unrounded): $1.3718; ministry $1.3718 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02315432 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=80097
Interchangeable products
Apo-Levofloxacin · DIN 02284715 · $1.3718 Jamp Levofloxacin · DIN 02508451 · $1.3718 Levaquin · DIN 02236842 · not recorded Mint-Levofloxacin · DIN 02505819 · $1.3718 Novo-Levofloxacin · DIN 02248263 · $1.3718 Riva-Levofloxacin · DIN 02492733 · $1.3718 Sandoz Levofloxacin · DIN 02298643 · $1.3718
Shortage status: discontinued (August 28, 2025, reported by TEVA CANADA LIMITED); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02315432
Shortage record checked October 6, 2026

Apo-Levofloxacin · DIN 02284715 · 500 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Levofloxacin · DIN 02284715 Manufacturer: Apotex Inc.; listing date 2009-09-30 Health Canada: Marketed since 2009-06-24 · brand APO-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Apo-Levofloxacin: Formulary list price $1.37 per unit (the source does not state the unit; exact figure $1.3718). What the ministry pays, not the patient.

Ministry pays: $1.3718 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02284715)

Source record
DIN 02284715: Apo-Levofloxacin Raw flags: sec3=Y Item: 084000049; group id 134; item number 0226; lccId None; manufacturer id APX Source form: Tab; strength: 500mg Recorded listing: General benefit Source prices (unrounded): $1.3718; ministry $1.3718 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02284715 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77027
Interchangeable products
Act Levofloxacin · DIN 02315432 · $1.3718 Jamp Levofloxacin · DIN 02508451 · $1.3718 Levaquin · DIN 02236842 · not recorded Mint-Levofloxacin · DIN 02505819 · $1.3718 Novo-Levofloxacin · DIN 02248263 · $1.3718 Riva-Levofloxacin · DIN 02492733 · $1.3718 Sandoz Levofloxacin · DIN 02298643 · $1.3718
Shortage status: shortage reported ended August 27, 2026 (report last updated August 27, 2026); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02284715
Shortage record checked October 6, 2026

Jamp Levofloxacin · DIN 02508451 · 500 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Jamp Levofloxacin · DIN 02508451 Manufacturer: Jamp Pharma Corporation; listing date 2024-09-27 Health Canada: Marketed since 2024-07-19 · brand JAMP LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Jamp Levofloxacin: Formulary list price $1.37 per unit (the source does not state the unit; exact figure $1.3718). What the ministry pays, not the patient.

Ministry pays: $1.3718 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02508451)

Source record
DIN 02508451: Jamp Levofloxacin Raw flags: sec3=Y Item: 084000049; group id 134; item number 0226; lccId None; manufacturer id JPC Source form: Tab; strength: 500mg Recorded listing: General benefit Source prices (unrounded): $1.3718; ministry $1.3718 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02508451 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99782
Interchangeable products
Act Levofloxacin · DIN 02315432 · $1.3718 Apo-Levofloxacin · DIN 02284715 · $1.3718 Levaquin · DIN 02236842 · not recorded Mint-Levofloxacin · DIN 02505819 · $1.3718 Novo-Levofloxacin · DIN 02248263 · $1.3718 Riva-Levofloxacin · DIN 02492733 · $1.3718 Sandoz Levofloxacin · DIN 02298643 · $1.3718
Shortage status: resolved shortage (ended January 9, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02508451
Shortage record checked October 6, 2026

Sandoz Levofloxacin · DIN 02298643 · 500 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Sandoz Levofloxacin · DIN 02298643 Manufacturer: Sandoz Canada Inc.; listing date 2009-09-30 Health Canada: Marketed since 2009-06-24 · brand SANDOZ LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG · company Sandoz canada incorporated · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Sandoz Levofloxacin: Formulary list price $1.37 per unit (the source does not state the unit; exact figure $1.3718). What the ministry pays, not the patient.

Ministry pays: $1.3718 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02298643)

Source record
DIN 02298643: Sandoz Levofloxacin Raw flags: sec3=Y Item: 084000049; group id 134; item number 0226; lccId None; manufacturer id SDZ Source form: Tab; strength: 500mg Recorded listing: General benefit Source prices (unrounded): $1.3718; ministry $1.3718 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02298643 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=78396
Interchangeable products
Act Levofloxacin · DIN 02315432 · $1.3718 Apo-Levofloxacin · DIN 02284715 · $1.3718 Jamp Levofloxacin · DIN 02508451 · $1.3718 Levaquin · DIN 02236842 · not recorded Mint-Levofloxacin · DIN 02505819 · $1.3718 Novo-Levofloxacin · DIN 02248263 · $1.3718 Riva-Levofloxacin · DIN 02492733 · $1.3718
Shortage status: resolved shortage (ended July 21, 2025); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02298643
Shortage record checked October 6, 2026

Act Levofloxacin · DIN 02315440 · 750 mg · tablet

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Act Levofloxacin · DIN 02315440 Manufacturer: Teva Canada Limited; listing date 2009-09-30 Health Canada: Marketed since 2025-10-16 · brand TEVA-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02315440)

Source record
DIN 02315440: Act Levofloxacin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 084000075; group id 134; item number 0227; lccId None; manufacturer id TEV Source form: Tab; strength: 750mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $6.5484; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02315440 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=80098
Interchangeable products
Apo-Levofloxacin · DIN 02325942 · not recorded Jamp Levofloxacin · DIN 02508478 · not recorded Levaquin · DIN 02246804 · not recorded Mint-Levofloxacin · DIN 02505800 · not recorded Novo-Levofloxacin · DIN 02285649 · not recorded Riva-Levofloxacin · DIN 02492741 · not recorded Sandoz Levofloxacin · DIN 02298651 · not recorded
Shortage status: discontinued (August 28, 2025, reported by TEVA CANADA LIMITED); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02315440
Shortage record checked October 6, 2026

Apo-Levofloxacin · DIN 02325942 · 750 mg · tablet

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Levofloxacin · DIN 02325942 Manufacturer: Apotex Inc.; listing date 2009-09-30 Health Canada: Marketed since 2009-06-24 · brand APO-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02325942)

Source record
DIN 02325942: Apo-Levofloxacin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 084000075; group id 134; item number 0227; lccId None; manufacturer id APX Source form: Tab; strength: 750mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $6.5484; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02325942 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81129
Interchangeable products
Act Levofloxacin · DIN 02315440 · not recorded Jamp Levofloxacin · DIN 02508478 · not recorded Levaquin · DIN 02246804 · not recorded Mint-Levofloxacin · DIN 02505800 · not recorded Novo-Levofloxacin · DIN 02285649 · not recorded Riva-Levofloxacin · DIN 02492741 · not recorded Sandoz Levofloxacin · DIN 02298651 · not recorded
Shortage status: shortage reported ended May 1, 2026 (report last updated May 1, 2026); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02325942
Shortage record checked October 6, 2026

Jamp Levofloxacin · DIN 02508478 · 750 mg · tablet

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Jamp Levofloxacin · DIN 02508478 Manufacturer: Jamp Pharma Corporation; listing date 2024-07-31 Health Canada: Marketed since 2024-07-22 · brand JAMP LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02508478)

Source record
DIN 02508478: Jamp Levofloxacin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 084000075; group id 134; item number 0227; lccId None; manufacturer id JPC Source form: Tab; strength: 750mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $6.5484; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02508478 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99783
Interchangeable products
Act Levofloxacin · DIN 02315440 · not recorded Apo-Levofloxacin · DIN 02325942 · not recorded Levaquin · DIN 02246804 · not recorded Mint-Levofloxacin · DIN 02505800 · not recorded Novo-Levofloxacin · DIN 02285649 · not recorded Riva-Levofloxacin · DIN 02492741 · not recorded Sandoz Levofloxacin · DIN 02298651 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02508478
Shortage record checked October 6, 2026

Sandoz Levofloxacin · DIN 02298651 · 750 mg · tablet

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Sandoz Levofloxacin · DIN 02298651 Manufacturer: Sandoz Canada Inc.; listing date 2009-11-13 Health Canada: Marketed since 2009-06-24 · brand SANDOZ LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG · company Sandoz canada incorporated · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02298651)

Source record
DIN 02298651: Sandoz Levofloxacin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 084000075; group id 134; item number 0227; lccId None; manufacturer id SDZ Source form: Tab; strength: 750mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $6.5484; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02298651 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=78397
Interchangeable products
Act Levofloxacin · DIN 02315440 · not recorded Apo-Levofloxacin · DIN 02325942 · not recorded Jamp Levofloxacin · DIN 02508478 · not recorded Levaquin · DIN 02246804 · not recorded Mint-Levofloxacin · DIN 02505800 · not recorded Novo-Levofloxacin · DIN 02285649 · not recorded Riva-Levofloxacin · DIN 02492741 · not recorded
Shortage status: resolved shortage (ended August 5, 2024); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02298651
Shortage record checked October 6, 2026

Riva-Levofloxacin · DIN 02492725 · 250 mg · tablet

General benefitDormant since November 8, 2023 · checked October 5, 2026 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Riva-Levofloxacin · DIN 02492725 Manufacturer: Laboratoire Riva Inc.; listing date 2020-06-30 Health Canada: Dormant since 2023-11-08 · brand RIVA-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG · company Laboratoire riva inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Riva-Levofloxacin: Formulary list price $1.20 per unit (the source does not state the unit; exact figure $1.2038). What the ministry pays, not the patient.

Ministry pays: $1.2038 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02492725)

Source record
DIN 02492725: Riva-Levofloxacin Raw flags: sec3=Y Item: 084000051; group id 134; item number 0225; lccId None; manufacturer id RIA Source form: Tab; strength: 250mg Recorded listing: General benefit Source prices (unrounded): $1.2038; ministry $1.2038 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02492725 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98271
Interchangeable products
Act Levofloxacin · DIN 02315424 · $1.2038 Apo-Levofloxacin · DIN 02284707 · $1.2038 Jamp Levofloxacin · DIN 02508443 · $1.2038 Levaquin · DIN 02236841 · not recorded Mint-Levofloxacin · DIN 02505797 · $1.2038 Novo-Levofloxacin · DIN 02248262 · $1.2038 Sandoz Levofloxacin · DIN 02298635 · $1.2038
Shortage status: discontinued (December 1, 2023, reported by LABORATOIRE RIVA INC.); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02492725
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since November 8, 2023 — choose a marketed DIN from the same-category list.

Riva-Levofloxacin · DIN 02492733 · 500 mg · tablet

General benefitDormant since January 19, 2023 · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Riva-Levofloxacin · DIN 02492733 Manufacturer: Laboratoire Riva Inc.; listing date 2020-06-30 Health Canada: Dormant since 2023-01-19 · brand RIVA-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG · company Laboratoire riva inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Riva-Levofloxacin: Formulary list price $1.37 per unit (the source does not state the unit; exact figure $1.3718). What the ministry pays, not the patient.

Ministry pays: $1.3718 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02492733)

Source record
DIN 02492733: Riva-Levofloxacin Raw flags: sec3=Y Item: 084000049; group id 134; item number 0226; lccId None; manufacturer id RIA Source form: Tab; strength: 500mg Recorded listing: General benefit Source prices (unrounded): $1.3718; ministry $1.3718 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02492733 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98272
Interchangeable products
Act Levofloxacin · DIN 02315432 · $1.3718 Apo-Levofloxacin · DIN 02284715 · $1.3718 Jamp Levofloxacin · DIN 02508451 · $1.3718 Levaquin · DIN 02236842 · not recorded Mint-Levofloxacin · DIN 02505819 · $1.3718 Novo-Levofloxacin · DIN 02248263 · $1.3718 Sandoz Levofloxacin · DIN 02298643 · $1.3718
Shortage status: discontinued (January 18, 2023, reported by LABORATOIRE RIVA INC.); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02492733
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since January 19, 2023 — choose a marketed DIN from the same-category list.

Riva-Levofloxacin · DIN 02492741 · 750 mg · tablet

Off-Formulary Interchangeable, not an ODB benefitDormant since January 9, 2023 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Riva-Levofloxacin · DIN 02492741 Manufacturer: Laboratoire Riva Inc.; listing date 2020-08-28 Health Canada: Dormant since 2023-01-09 · brand RIVA-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG · company Laboratoire riva inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02492741)

Source record
DIN 02492741: Riva-Levofloxacin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 084000075; group id 134; item number 0227; lccId None; manufacturer id RIA Source form: Tab; strength: 750mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $6.5484; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02492741 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98273
Interchangeable products
Act Levofloxacin · DIN 02315440 · not recorded Apo-Levofloxacin · DIN 02325942 · not recorded Jamp Levofloxacin · DIN 02508478 · not recorded Levaquin · DIN 02246804 · not recorded Mint-Levofloxacin · DIN 02505800 · not recorded Novo-Levofloxacin · DIN 02285649 · not recorded Sandoz Levofloxacin · DIN 02298651 · not recorded
Shortage status: discontinued (December 22, 2022, reported by LABORATOIRE RIVA INC.); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02492741
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since January 9, 2023 — choose a marketed DIN from the same-category list.

Mint-Levofloxacin · DIN 02505797 · 250 mg · tablet

General benefit; Health Canada lists this DIN as Cancelled post market since 2026-04-02 — choose a marketed DIN from the same-category list.Discontinued April 2, 2026 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2026-04-02 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2026-04-02 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Mint-Levofloxacin · DIN 02505797 Manufacturer: Mint Pharmaceuticals Inc.; listing date 2021-10-29 Health Canada: Cancelled post market since 2026-04-02 · brand MINT-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG · company Mint pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Mint-Levofloxacin: Formulary list price $1.20 per unit (the source does not state the unit; exact figure $1.2038). What the ministry pays, not the patient.

Ministry pays: $1.2038 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02505797)

Source record
DIN 02505797: Mint-Levofloxacin Raw flags: sec3=Y Item: 084000051; group id 134; item number 0225; lccId None; manufacturer id MIN Source form: Tab; strength: 250mg Recorded listing: General benefit Source prices (unrounded): $1.2038; ministry $1.2038 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02505797 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99517
Interchangeable products
Act Levofloxacin · DIN 02315424 · $1.2038 Apo-Levofloxacin · DIN 02284707 · $1.2038 Jamp Levofloxacin · DIN 02508443 · $1.2038 Levaquin · DIN 02236841 · not recorded Novo-Levofloxacin · DIN 02248262 · $1.2038 Riva-Levofloxacin · DIN 02492725 · $1.2038 Sandoz Levofloxacin · DIN 02298635 · $1.2038
Shortage status: discontinued (October 2, 2022, reported by MINT PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02505797
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 2, 2026 — choose a marketed DIN from the same-category list.

Novo-Levofloxacin · DIN 02248262 · 250 mg · tablet

General benefit; Health Canada lists this DIN as Cancelled post market since 2019-05-01 — choose a marketed DIN from the same-category list.Discontinued May 1, 2019 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2019-05-01 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2019-05-01 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Novo-Levofloxacin · DIN 02248262 Manufacturer: Novopharm Ltd.; listing date 2005-01-25 Health Canada: Cancelled post market since 2019-05-01 · brand TEVA-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 250 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Novo-Levofloxacin: Formulary list price $1.20 per unit (the source does not state the unit; exact figure $1.2038). What the ministry pays, not the patient.

Ministry pays: $1.2038 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248262)

Source record
DIN 02248262: Novo-Levofloxacin Raw flags: sec3=Y Item: 084000051; group id 134; item number 0225; lccId None; manufacturer id NOP Source form: Tab; strength: 250mg Recorded listing: General benefit Source prices (unrounded): $1.2038; ministry $1.2038 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248262 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=72599
Interchangeable products
Act Levofloxacin · DIN 02315424 · $1.2038 Apo-Levofloxacin · DIN 02284707 · $1.2038 Jamp Levofloxacin · DIN 02508443 · $1.2038 Levaquin · DIN 02236841 · not recorded Mint-Levofloxacin · DIN 02505797 · $1.2038 Riva-Levofloxacin · DIN 02492725 · $1.2038 Sandoz Levofloxacin · DIN 02298635 · $1.2038
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02248262
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since May 1, 2019 — choose a marketed DIN from the same-category list.

Mint-Levofloxacin · DIN 02505819 · 500 mg · tablet

General benefit; Health Canada lists this DIN as Cancelled post market since 2026-04-02 — choose a marketed DIN from the same-category list.Discontinued April 2, 2026 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2026-04-02 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2026-04-02 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Mint-Levofloxacin · DIN 02505819 Manufacturer: Mint Pharmaceuticals Inc.; listing date 2021-10-29 Health Canada: Cancelled post market since 2026-04-02 · brand MINT-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG · company Mint pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Mint-Levofloxacin: Formulary list price $1.37 per unit (the source does not state the unit; exact figure $1.3718). What the ministry pays, not the patient.

Ministry pays: $1.3718 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02505819)

Source record
DIN 02505819: Mint-Levofloxacin Raw flags: sec3=Y Item: 084000049; group id 134; item number 0226; lccId None; manufacturer id MIN Source form: Tab; strength: 500mg Recorded listing: General benefit Source prices (unrounded): $1.3718; ministry $1.3718 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02505819 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99519
Interchangeable products
Act Levofloxacin · DIN 02315432 · $1.3718 Apo-Levofloxacin · DIN 02284715 · $1.3718 Jamp Levofloxacin · DIN 02508451 · $1.3718 Levaquin · DIN 02236842 · not recorded Novo-Levofloxacin · DIN 02248263 · $1.3718 Riva-Levofloxacin · DIN 02492733 · $1.3718 Sandoz Levofloxacin · DIN 02298643 · $1.3718
Shortage status: discontinued (October 2, 2022, reported by MINT PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02505819
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 2, 2026 — choose a marketed DIN from the same-category list.

Novo-Levofloxacin · DIN 02248263 · 500 mg · tablet

General benefit; Health Canada lists this DIN as Cancelled post market since 2019-05-01 — choose a marketed DIN from the same-category list.Discontinued May 1, 2019 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2019-05-01 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2019-05-01 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Novo-Levofloxacin · DIN 02248263 Manufacturer: Novopharm Ltd.; listing date 2005-01-25 Health Canada: Cancelled post market since 2019-05-01 · brand TEVA-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 500 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Novo-Levofloxacin: Formulary list price $1.37 per unit (the source does not state the unit; exact figure $1.3718). What the ministry pays, not the patient.

Ministry pays: $1.3718 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248263)

Source record
DIN 02248263: Novo-Levofloxacin Raw flags: sec3=Y Item: 084000049; group id 134; item number 0226; lccId None; manufacturer id NOP Source form: Tab; strength: 500mg Recorded listing: General benefit Source prices (unrounded): $1.3718; ministry $1.3718 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248263 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=72600
Interchangeable products
Act Levofloxacin · DIN 02315432 · $1.3718 Apo-Levofloxacin · DIN 02284715 · $1.3718 Jamp Levofloxacin · DIN 02508451 · $1.3718 Levaquin · DIN 02236842 · not recorded Mint-Levofloxacin · DIN 02505819 · $1.3718 Riva-Levofloxacin · DIN 02492733 · $1.3718 Sandoz Levofloxacin · DIN 02298643 · $1.3718
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02248263
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since May 1, 2019 — choose a marketed DIN from the same-category list.

Levaquin · DIN 02236841 · 250 mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2014-10-27 — choose a marketed DIN from the same-category list.Discontinued October 27, 2014 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2014-10-27 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2014-10-27 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Levaquin · DIN 02236841 Manufacturer: Janssen Inc.; listing date 1999-09-15 Health Canada: Cancelled post market since 2014-10-27 · brand LEVAQUIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN 250 MG · company Janssen inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Levaquin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02236841)

Source record
DIN 02236841: Levaquin Raw flags: notABenefit=Y, sec3=Y Item: 084000051; group id 134; item number 0225; lccId None; manufacturer id JAN Source form: Tab; strength: 250mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02236841 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=60130
Interchangeable products
Act Levofloxacin · DIN 02315424 · $1.2038 Apo-Levofloxacin · DIN 02284707 · $1.2038 Jamp Levofloxacin · DIN 02508443 · $1.2038 Mint-Levofloxacin · DIN 02505797 · $1.2038 Novo-Levofloxacin · DIN 02248262 · $1.2038 Riva-Levofloxacin · DIN 02492725 · $1.2038 Sandoz Levofloxacin · DIN 02298635 · $1.2038
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02236841
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since October 27, 2014 — choose a marketed DIN from the same-category list.

Levaquin · DIN 02236842 · 500 mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2015-04-02 — choose a marketed DIN from the same-category list.Discontinued April 2, 2015 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2015-04-02 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2015-04-02 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Levaquin · DIN 02236842 Manufacturer: Janssen Inc.; listing date 1999-09-15 Health Canada: Cancelled post market since 2015-04-02 · brand LEVAQUIN 500MG · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN 500 MG · company Janssen inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Levaquin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02236842)

Source record
DIN 02236842: Levaquin Raw flags: notABenefit=Y, sec3=Y Item: 084000049; group id 134; item number 0226; lccId None; manufacturer id JAN Source form: Tab; strength: 500mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02236842 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=60131
Interchangeable products
Act Levofloxacin · DIN 02315432 · $1.3718 Apo-Levofloxacin · DIN 02284715 · $1.3718 Jamp Levofloxacin · DIN 02508451 · $1.3718 Mint-Levofloxacin · DIN 02505819 · $1.3718 Novo-Levofloxacin · DIN 02248263 · $1.3718 Riva-Levofloxacin · DIN 02492733 · $1.3718 Sandoz Levofloxacin · DIN 02298643 · $1.3718
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02236842
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 2, 2015 — choose a marketed DIN from the same-category list.

Levaquin · DIN 02246804 · 750 mg · tablet

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-03-27 — choose a marketed DIN from the same-category list.Discontinued March 27, 2015 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-03-27 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2015-03-27 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Levaquin · DIN 02246804 Manufacturer: Janssen Inc.; listing date 2009-09-30 Health Canada: Cancelled post market since 2015-03-27 · brand LEVAQUIN 750MG · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN 750 MG · company Janssen inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Levaquin: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02246804)

Source record
DIN 02246804: Levaquin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 084000075; group id 134; item number 0227; lccId None; manufacturer id JAN Source form: Tab; strength: 750mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02246804 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71004
Interchangeable products
Act Levofloxacin · DIN 02315440 · not recorded Apo-Levofloxacin · DIN 02325942 · not recorded Jamp Levofloxacin · DIN 02508478 · not recorded Mint-Levofloxacin · DIN 02505800 · not recorded Novo-Levofloxacin · DIN 02285649 · not recorded Riva-Levofloxacin · DIN 02492741 · not recorded Sandoz Levofloxacin · DIN 02298651 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02246804
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since March 27, 2015 — choose a marketed DIN from the same-category list.

Mint-Levofloxacin · DIN 02505800 · 750 mg · tablet

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2026-04-02 — choose a marketed DIN from the same-category list.Discontinued April 2, 2026 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2026-04-02 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2026-04-02 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Mint-Levofloxacin · DIN 02505800 Manufacturer: Mint Pharmaceuticals Inc.; listing date 2021-11-30 Health Canada: Cancelled post market since 2026-04-02 · brand MINT-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG · company Mint pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02505800)

Source record
DIN 02505800: Mint-Levofloxacin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 084000075; group id 134; item number 0227; lccId None; manufacturer id MIN Source form: Tab; strength: 750mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $6.5484; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02505800 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99518
Interchangeable products
Act Levofloxacin · DIN 02315440 · not recorded Apo-Levofloxacin · DIN 02325942 · not recorded Jamp Levofloxacin · DIN 02508478 · not recorded Levaquin · DIN 02246804 · not recorded Novo-Levofloxacin · DIN 02285649 · not recorded Riva-Levofloxacin · DIN 02492741 · not recorded Sandoz Levofloxacin · DIN 02298651 · not recorded
Shortage status: discontinued (October 2, 2022, reported by MINT PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02505800
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 2, 2026 — choose a marketed DIN from the same-category list.

Novo-Levofloxacin · DIN 02285649 · 750 mg · tablet

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2019-05-01 — choose a marketed DIN from the same-category list.Discontinued May 1, 2019 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2019-05-01 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2019-05-01 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Novo-Levofloxacin · DIN 02285649 Manufacturer: Novopharm Ltd.; listing date 2009-09-30 Health Canada: Cancelled post market since 2019-05-01 · brand TEVA-LEVOFLOXACIN · ATC J01MA12 LEVOFLOXACIN · form Tablet · route Oral · ingredients LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE) 750 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02285649)

Source record
DIN 02285649: Novo-Levofloxacin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 084000075; group id 134; item number 0227; lccId None; manufacturer id NOP Source form: Tab; strength: 750mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $6.5484; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02285649 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77115
Interchangeable products
Act Levofloxacin · DIN 02315440 · not recorded Apo-Levofloxacin · DIN 02325942 · not recorded Jamp Levofloxacin · DIN 02508478 · not recorded Levaquin · DIN 02246804 · not recorded Mint-Levofloxacin · DIN 02505800 · not recorded Riva-Levofloxacin · DIN 02492741 · not recorded Sandoz Levofloxacin · DIN 02298651 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02285649
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since May 1, 2019 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (J01MA): coverage varies; not interchangeable

  • Ciprofloxacin (Cipro): general benefit, limited Use 533, not a benefit
  • Moxifloxacin (Avelox): general benefit, not a benefit
  • Norfloxacin (Noroxin): general benefit, not a benefit
  • Ciprofloxacin + ciprofloxacin base (Cipro XL): limited Use 394, not a benefit
Other drugs in the same formulary class (08:40 Miscellaneous Anti-Infectives) and how they are covered

Matched class: 08:40 Miscellaneous Anti-Infectives

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): CIPROFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, NORFLOXACIN, SULFAMETHOXAZOLE & TRIMETHOPRIM, TRIMETHOPRIM 08:40 Miscellaneous Anti-Infectives

CIPROFLOXACIN

· 44 products · Limited Use, codes 533 (1), Listed, not a benefit (3), General benefit (40) · strengths: 10g/100mL, 250mg, 500mg, 750mg · Oral Susp, Tab

MOXIFLOXACIN HYDROCHLORIDE

· 12 products · Listed, not a benefit (1), General benefit (11) · strengths: 400mg · Tab

NORFLOXACIN

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 400mg · Tab

CIPROFLOXACIN HCL & CIPROFLOXACIN BASE

· 2 products · Listed, not a benefit (1), Limited Use, codes 394 (1) · strengths: 500mg · ER Tab

SULFAMETHOXAZOLE & TRIMETHOPRIM

· 9 products · Listed, not a benefit (6), General benefit (3) · strengths: 40mg & 8mg/mL, 400mg & 80mg, 800mg & 160mg · O/L, Tab

TRIMETHOPRIM

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 100mg, 200mg · Tab

LINEZOLID

· 7 products · Off-Formulary Interchangeable, not an ODB benefit (3), Listed, not a benefit (1), Limited Use, codes 362, 363, 364 (3) · strengths: 2mg/mL, 600mg · Inj-300mL Pk, Tab

CEFEPIME

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1g, 2g · Inj Pd-Vial Pk

ERTAPENEM

· 5 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1g/Vial · Inj Pd-Vial Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 08:40
Full class listing Related classes: 08:08 Anthelmintics, 08:12 Antibiotics, 08:14 Antifungals, 08:16 Antitubercular Agents, 08:18 Antivirals, 08:20 Plasmodicides (Antimalarials), 08:24 Sulfonamides, 08:30 Antiprotozoals, 08:32 Trichomonacides, 08:36 Urinary Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS APO-LEVOFLOXACIN (levofloxacin tablets) are indicated for the treatment of adults with bacterial infections caused by susceptible strains of the designated microorganisms in the infections listed below. • To reduce the development of drug-resistant bacteria and maintain the effectiveness of APO- LEVOFLOXACIN and other antibacterial drugs, APO-LEVOFLOXACIN should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. • Upper Respiratory Tract Acute bacterial sinusitis (mild to moderate) due to Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella (Branhamella) catarrhalis. Restrict the use of APO-LEVOFLOXACIN to settings where no other treatment options exist, and the clinical presentation meets the diagnostic criteria for acute bacterial sinusitis.1 • Lower Respiratory Tract Acute bacterial exacerbations of chronic bron… https://pdf.hres.ca/dpd_pm/00078730.PDF PM date: JUN 24, 2009 Source product: APO-LEVOFLOXACIN; DIN 02284707; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Act Levofloxacin · DIN 02315424 Shortage status: discontinued (2025-08-28, reported by TEVA CANADA LIMITED); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02315424

Check this DIN again

Apo-Levofloxacin · DIN 02284707 Shortage status: shortage reported ended 2026-05-01 (report last updated 2026-05-01); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02284707

Check this DIN again

Act Levofloxacin · DIN 02315432 Shortage status: discontinued (2025-08-28, reported by TEVA CANADA LIMITED); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02315432

Check this DIN again

Apo-Levofloxacin · DIN 02284715 Shortage status: shortage reported ended 2026-08-27 (report last updated 2026-08-27); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02284715

Check this DIN again

Act Levofloxacin · DIN 02315440 Shortage status: discontinued (2025-08-28, reported by TEVA CANADA LIMITED); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02315440

Check this DIN again

Apo-Levofloxacin · DIN 02325942 Shortage status: shortage reported ended 2026-05-01 (report last updated 2026-05-01); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02325942

Check this DIN again

Riva-Levofloxacin · DIN 02492725 Shortage status: discontinued (2023-12-01, reported by LABORATOIRE RIVA INC.); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02492725

Check this DIN again

Riva-Levofloxacin · DIN 02492733 Shortage status: discontinued (2023-01-18, reported by LABORATOIRE RIVA INC.); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02492733

Check this DIN again

Riva-Levofloxacin · DIN 02492741 Shortage status: discontinued (2022-12-22, reported by LABORATOIRE RIVA INC.); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02492741

Check this DIN again

Mint-Levofloxacin · DIN 02505797 Shortage status: discontinued (2022-10-02, reported by MINT PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02505797

Check this DIN again

Mint-Levofloxacin · DIN 02505819 Shortage status: discontinued (2022-10-02, reported by MINT PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02505819

Check this DIN again

Mint-Levofloxacin · DIN 02505800 Shortage status: discontinued (2022-10-02, reported by MINT PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02505800

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, September 10, 2026 ↗)

Other review policies

For Act Levofloxacin, Apo-Levofloxacin, Jamp Levofloxacin, Sandoz Levofloxacin, Riva-Levofloxacin, Levaquin, Mint-Levofloxacin, Novo-Levofloxacin: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026